Management of Neonatal Herpes Simplex Virus Infection

Document Type


Publication Date



Neonatal Herpes Simplex Virus (HSV) infection is an uncommon disease but one that continues to cause significant motility and mortality among newborns. The untreated disseminated disease causes 85% mortality rate and more than 75% of these newborns develop serious neurological complications. A timely diagnosis of the HSV in pregnant women and effective management of the HSV infection during pregnancy with suppressive acyclovir administration and the correct decision on the mode of delivery may reduce the chance of HSV transmission to a newborn. Current advantages in the treatment of the neonatal HSV infection based on a prolonged oral suppressive acyclovir treatment helps to improve neurodevelopmental outcome and prognosis of neonatal HSV diseases.

Research Area

Physician Assistant Studies

This document is currently not available here.